Professional Documents
Culture Documents
should create a positive synergy, unlocking a new source of growth. 4,500 112
Pegadaian and PNM’s 9M21 NIMs are 19% and 17%, much higher than 4,300 108
BBRI’s consolidated NIM of 6.9%. However, Pegadaian and PNM’s CIRs 4,100 104
3,900 100
are much higher (63% and 78.8%) vs BBRI’s consolidated (44.7%). BBRI 3,700 96
is to lower operational expenses of Pegadaian and PNM – which was 3,500 92
acquired on 13 Sep – to boost its consolidated earnings. In 2022, the bank 3,300 88
will book full earnings from Pegadaian and PNM vs just one quarter in 2021. 3,100 84
May-21
Jul-21
Jul-21
Oct-20
Feb-21
Feb-21
Mar-21
Mar-21
Apr-21
Apr-21
Nov-20
Nov-20
Dec-20
Oct-21
Jan-21
Jan-21
Jun-21
Jun-21
Aug-21
Aug-21
Sep-21
Sep-21
Lower FY21F-22F earnings by 14% and 9% to IDR28-38trn, driven by
higher provision expense as we become more conservative compared to Source: Bloomberg
our previous forecasts. However, our new GGM-based TP rises slightly to
IDR4,800 after factoring in an 8% premium based on our proprietary in-
house ESG methodology, which derived a score of 3.40.
Key risk in our call is a possibility of a third wave of COVID-19, which may
cause slower loan growth and increased NPL Overall ESG Score: 3.40 (out of 4)
E: Excellent
The BRI Peduli - Indonesia Lestari aims to support marine
sustainability (such as planting mangrove seeds, etc). Re-
engineering its credit card application process to make it
paperless by moving it entirely online. To accelerate river
revitalisation in a number of areas. BBRI’s CSR programme
“Clean the River” is being carried out in 19 rivers, at 19 of
its regional offices throughout Indonesia.
S: Excellent
BBRI implements labour rights in accordance with local
Forecasts and Valuation Dec-19 Dec-20 Dec-21F Dec-22F labour laws and continuously monitors labour issues such
Reported net profit (IDRb) 34,373 18,655 28,343 38,127 as child labour, forced labour, freedom of association,
discrimination, and gender equality etc. It carries out
Net profit growth (%) 6.2 (45.7) 51.9 34.5
community empowerment activities such as education and
Recurring net profit (IDRb) 34,426 18,700 28,397 38,183 training activities on green businesses.
Recurring EPS (IDR) 281.64 152.99 232.31 312.37
BVPS (IDR) 1,687.90 1,614.71 1,996.08 2,260.92 G: Excellent
DPS (IDR) 138.61 na 61.04 92.75
As the first mover in the implementation of sustainable
finance, BBRI continues to strengthen its sustainability
Recurring P/E (x) 15.45 28.43 18.73 13.93
governance structure under the Director of Risk
P/B (x) 2.58 2.69 2.18 1.92 Management, who is responsible for the implementation of
Dividend Yield (%) 3.2 na 1.4 2.1 sustainable finance.
equity (%)
Return on average assets (%) 17.7
2.5 9.2
1.3 12.8
1.7 14.7
2.1
Source: Company data, RHB
Financial Exhibits
Asia Financial summary (IDR) Dec-19 Dec-20 Dec-21F Dec-22F
Indonesia EPS 281.20 152.61 231.87 311.91
Financial Services Recurring EPS 281.64 152.99 232.31 312.37
Bank Rakyat Indonesia DPS 138.61 - 61.04 92.75
BBRI IJ BVPS 1,687.90 1,614.71 1,996.08 2,260.92
Buy
Valuation metrics Dec-19 Dec-20 Dec-21F Dec-22F
Recurring P/E (x) 15.45 28.43 18.73 13.93
Valuation basis
P/B (x) 2.6 2.7 2.2 1.9
P/BV backed by GGM. Assumptions include: Dividend Yield (%) 3.2 na 1.4 2.1
i. COE of 12.5%;
ii. ROE of 16%;
iii. 9.6% long-term growth. Income statement (IDRb) Dec-19 Dec-20 Dec-21F Dec-22F
Interest income 121,756 116,933 134,433 147,658
Interest expense (40,049) (37,723) (40,040) (44,581)
Key drivers Net interest income 81,707 79,210 94,393 103,077
Non interest income 29,450 30,345 33,344 37,304
i. Faster-than-expected loan growth;
ii. Lower cost of funds; Total operating income 111,157 109,555 127,738 140,382
iii. Improvements in asset quality Overheads (44,966) (52,148) (56,841) (61,957)
Pre-provision operating profit 66,192 57,408 70,897 78,425
Loan impairment allowances (21,493) (28,780) (32,294) (27,015)
Key risks Other impairment allowances (1,267) (1,837) (2,021) (2,223)
Possibility of a third wave of COVID-19 which may Other exceptional items (68) (65) (69) (72)
cause slower loan growth and increased NPL Pre-tax profit 43,364 26,725 36,513 49,115
Taxation (8,950) (8,064) (8,164) (10,981)
Minority interests (41) (6) (6) (7)
Company Profile Reported net profit 34,373 18,655 28,343 38,127
Bank Rakyat Indonesia is the largest bank in Indonesia, Recurring net profit 34,426 18,700 28,397 38,183
with assets totalling IDR1,418trn. It focuses on loans in
the micro and small enterprises segment. Profitability ratios Dec-19 Dec-20 Dec-21F Dec-22F
Return on average assets (%) 2.5 1.3 1.7 2.1
Return on average equity (%) 17.7 9.2 12.8 14.7
Return on IEAs (%) 9.6 8.9 9.2 8.7
Cost of funds (%) 4.0 3.5 3.2 3.2
Net interest spread (%) 5.6 5.4 5.9 5.5
Net interest margin (%) 6.4 6.0 6.4 6.1
Non-interest income / total income (%) 26.5 27.7 26.1 26.6
Cost to income ratio (%) 40.5 47.6 44.5 44.1
Credit cost (bps) 247 313 332 260
Non-Interest Income 8,798 8,503 8,667 1.9% -1.5% 22,512 25,893 15.0%
Total Operating Income 30,295 32,461 33,214 2.3% 9.6% 78,561 97,583 24.2%
Operating Expense 15,122 13,089 15,652 19.6% 3.5% 38,732 41,860 8.1%
PPOP 15,173 19,372 17,562 -9.3% 15.7% 39,829 55,723 39.9%
Provision Expense 10,196 11,910 8,641 -27.4% -15.3% 19,396 30,370 56.6%
Operating Profit 4,977 7,462 8,921 19.6% 79.2% 20,433 25,353 24.1%
Net Profit 3,953 5,680 6,530 15.0% 65.2% 14,154 19,070 34.7% 58% 65%
BALANCE SHEET (IDRbn) 9M20 6M21 9M21 QoQ YoY 9M20 9M21 YoY
Loan 934,138 912,072 1,026,424 12.5% 9.9% 934,138 1,026,424 9.9%
Deposit 1,131,928 1,079,073 1,189,304 10.2% 5.1% 1,131,928 1,189,304 5.1%
CASA 668,097 648,538 730,599 12.7% 9.4% 668,097 730,599 9.4%
Time Deposits 463,830 430,535 458,705 6.5% -1.1% 463,830 458,705 -1.1%
1.6
-2 SD = 1.4x
1.4
1.2
2015
2016
2017
2018
2019
2020
2021
Recommendation Chart
Date Recommendation Target Price Price
Price Close
2021-02-01 Buy 4,790 4,400
5,400 Recommendations & Target Price
2020-12-10 Buy 5,100 4,330
na
4,000
4,750
5,000
5,000
4,400
3,600
3,700
3,700
4,000
4,790
4,900 2020-11-12 Neutral 4,000 3,950
3,400
5,100
2020-08-23 Neutral 3,700 3,560
4,400
2020-07-15 Buy 3,700 3,130
3,900 2020-05-15 Buy 3,400 2,240
2020-04-16 Buy 3,600 2,610
3,400
2020-03-11 Neutral 4,400 3,910
2,900 2020-01-24 Neutral 5,000 4,740
1,900 Buy Neutral Sell Trading Buy Take Profit Not Rated Source: RHB, Bloomberg
Oct-16 Feb-18 May-19 Aug-20
Source: RHB, Bloomberg
3.4 3.4
3.0
2.0
1.0
0.0
Source: RHB
5
member of the Stock Exchange of Thailand. The Thai Institute of Directors Association 1. RHBIB does not have a financial interest in the securities or other capital market
has disclosed the Corporate Governance Report of Thai Listed Companies made products of the subject company(ies) covered in this report.
pursuant to the policy of the Securities and Exchange Commission of Thailand. RHB 2. RHBIB is not a market maker in the securities or capital market products of the
Securities (Thailand) PCL does not endorse, confirm nor certify the result of the Corporate subject company(ies) covered in this report.
Governance Report of Thai Listed Companies. 3. None of RHBIB’s staff or associated person serve as a director or board member*
of the subject company(ies) covered in this report
Indonesia *For the avoidance of doubt, the confirmation is only limited to the staff of research
This report is issued and distributed in Indonesia by PT RHB Sekuritas Indonesia. This department
research does not constitute an offering document and it should not be construed as 4. RHBIB did not receive compensation for investment banking or corporate finance
an offer of securities in Indonesia. Any securities offered or sold, directly or indirectly, services from the subject company in the past 12 months.
in Indonesia or to any Indonesian citizen or corporation (wherever located) or to any 5. RHBIB did not receive compensation or benefit (including gift and special cost
Indonesian resident in a manner which constitutes a public offering under Indonesian arrangement e.g. company/issuer-sponsored and paid trip) in relation to the
laws and regulations must comply with the prevailing Indonesian laws and regulations. production of this report.
Singapore Thailand
This report is issued and distributed in Singapore by RHB Bank Berhad (through its Save as disclosed in the following link RHB Research conflict disclosures – Oct 2021
Singapore branch) which is an exempt capital markets services entity and an exempt and to the best of our knowledge, RHB Securities (Thailand) PCL hereby declares that:
financial adviser regulated by the Monetary Authority of Singapore. RHB Bank Berhad 1. RHB Securities (Thailand) PCL does not have a financial interest in the securities
(through its Singapore branch) may distribute reports produced by its respective or other capital market products of the subject company(ies) covered in this report.
foreign entities, affiliates or other foreign research houses pursuant to an arrangement 2. RHB Securities (Thailand) PCL is not a market maker in the securities or capital
under Regulation 32C of the Financial Advisers Regulations. Where the report is market products of the subject company(ies) covered in this report.
distributed in Singapore to a person who is not an Accredited Investor, Expert Investor 3. None of RHB Securities (Thailand) PCL’s staff or associated person serve as a
or an Institutional Investor, RHB Bank Berhad (through its Singapore branch) accepts director or board member* of the subject company(ies) covered in this report
legal responsibility for the contents of the report to such persons only to the extent 1. *For the avoidance of doubt, the confirmation is only limited to the staff of research
required by law. Singapore recipients should contact RHB Bank Berhad (through its department
Singapore branch) in respect of any matter arising from or in connection with the report. 4. RHB Securities (Thailand) PCL did not receive compensation for investment
banking or corporate finance services from the subject company in the past 12
United States months.
This report was prepared by RHB is meant for distribution solely and directly to “major” 5. RHB Securities (Thailand) PCL did not receive compensation or benefit (including
U.S. institutional investors as defined under, and pursuant to, the requirements of Rule gift and special cost arrangement e.g. company/issuer-sponsored and paid trip) in
15a-6 under the U.S. Securities and Exchange Act of 1934, as amended (the relation to the production of this report.
“Exchange Act”) via a registered U.S. broker-dealer as appointed by RHB from time to
time. Accordingly, any access to this report via Bursa Marketplace or any other Indonesia
Electronic Services Provider is not intended for any party other than “major” US Save as disclosed in the following link RHB Research conflict disclosures – Oct 2021
institutional investors (via a registered U.S broker-dealer), nor shall be deemed as and to the best of our knowledge, PT RHB Sekuritas Indonesia hereby declares that:
solicitation by RHB in any manner. RHB is not registered as a broker-dealer in the 1. PT RHB Sekuritas Indonesia and its investment analysts, does not have any
United States and currently has not appointed a U.S. broker-dealer. Additionally, RHB interest in the securities of the subject company(ies) covered in this report.
does not offer brokerage services to U.S. persons. Any order for the purchase or sale For the avoidance of doubt, interest in securities include the following:
of all securities discussed herein must be placed with and through a registered U.S. a) Holding directly or indirectly, individually or jointly own/hold securities or
broker-dealer as appointed by RHB from time to time as required by the Exchange Act entitled for dividends, interest or proceeds from the sale or exercise of the
Rule 15a-6. For avoidance of doubt, RHB reiterates that it has not appointed any U.S. subject company’s securities covered in this report*;
broker-dealer during the issuance of this report. This report is confidential and not b) Being bound by an agreement to purchase securities or has the right to
intended for distribution to, or use by, persons other than the recipient and its transfer the securities or has the right to pre subscribe the securities*.
employees, agents and advisors, as applicable. Additionally, where research is c) Being bound or required to buy the remaining securities that are not
distributed via Electronic Service Provider, the analysts whose names appear in this subscribed/placed out pursuant to an Initial Public Offering*.
report are not registered or qualified as research analysts in the United States and are d) Managing or jointly with other parties managing such parties as referred to in
not associated persons of any registered U.S. broker-dealer as appointed by RHB (a), (b) or (c) above.
from time to time and therefore may not be subject to any applicable restrictions under 2. PT RHB Sekuritas Indonesia is not a market maker in the securities or capital
Financial Industry Regulatory Authority (“FINRA”) rules on communications with a market products of the subject company(ies) covered in this report.
subject company, public appearances and personal trading. Investing in any non-U.S. 3. None of PT RHB Sekuritas Indonesia’s staff** or associated person serve as a
securities or related financial instruments discussed in this research report may director or board member* of the subject company(ies) covered in this report.
present certain risks. The securities of non-U.S. issuers may not be registered with, or 4. PT RHB Sekuritas Indonesia did not receive compensation for investment banking
be subject to the regulations of, the U.S. Securities and Exchange Commission. or corporate finance services from the subject company in the past 12 months.
Information on non-U.S. securities or related financial instruments may be limited. 5. PT RHB Sekuritas Indonesia** did not receive compensation or benefit (including
Foreign companies may not be subject to audit and reporting standards and regulatory gift and special cost arrangement e.g. company/issuer-sponsored and paid trip) in
requirements comparable to those in the United States. The financial instruments relation to the production of this report:
discussed in this report may not be suitable for all investors. Transactions in foreign Notes:
markets may be subject to regulations that differ from or offer less protection than *The overall disclosure is limited to information pertaining to PT RHB Sekuritas
those in the United States. Indonesia only.
**The disclosure is limited to Research staff of PT RHB Sekuritas Indonesia only.
DISCLOSURE OF CONFLICTS OF INTEREST
Singapore
RHB Investment Bank Berhad, its subsidiaries (including its regional offices) and Save as disclosed in the following link RHB Research conflict disclosures – Oct 2021
associated companies, (“RHBIB Group”) form a diversified financial group, and to the best of our knowledge, the Singapore Research department of RHB Bank
undertaking various investment banking activities which include, amongst others, Berhad (through its Singapore branch) hereby declares that:
underwriting, securities trading, market making and corporate finance advisory. 1. RHB Bank Berhad, its subsidiaries and/or associated companies do not make a
market in any issuer covered by the Singapore research analysts in this report.
As a result of the same, in the ordinary course of its business, any member of the 2. RHB Bank Berhad, its subsidiaries and/or its associated companies and its
RHBIB Group, may, from time to time, have business relationships with, hold any analysts do not have a financial interest (including a shareholding of 1% or more)
positions in the securities and/or capital market products (including but not limited to in the issuer covered by the Singapore research analysts in this report.
shares, warrants, and/or derivatives), trade or otherwise effect transactions for its own 3. RHB Bank Berhad’s Singapore research staff or connected persons do not serve
account or the account of its customers or perform and/or solicit investment, advisory on the board or trustee positions of the issuer covered by the Singapore research
or other services from any of the subject company(ies) covered in this research report. analysts in this report.
4. RHB Bank Berhad, its subsidiaries and/or its associated companies do not have
While the RHBIB Group will ensure that there are sufficient information barriers and and have not within the last 12 months had any corporate finance advisory
internal controls in place where necessary, to prevent/manage any conflicts of interest relationship with the issuer covered by the Singapore research analysts in this
to ensure the independence of this report, investors should also be aware that such report or any other relationship that may create a potential conflict of interest.
conflict of interest may exist in view of the investment banking activities undertaken by 5. RHB Bank Berhad’s Singapore research analysts, or person associated or
the RHBIB Group as mentioned above and should exercise their own judgement connected to it do not have any interest in the acquisition or disposal of, the
before making any investment decisions. securities, specified securities based derivatives contracts or units in a collective
investment scheme covered by the Singapore research analysts in this report.
In Singapore, investment research activities are conducted under RHB Bank Berhad 6. RHB Bank Berhad’s Singapore research analysts do not receive any
(through its Singapore branch), and the disclaimers above similarly apply. compensation or benefit in connection with the production of this research report
or recommendation on the issuer covered by the Singapore research analysts.
Malaysia
Save as disclosed in the following link RHB Research conflict disclosures – Oct 2021 Analyst Certification
and to the best of our knowledge, RHBIB hereby declares that: The analyst(s) who prepared this report, and their associates hereby, certify that:
6
(1) they do not have any financial interest in the securities or other capital market
products of the subject companies mentioned in this report, except for:
Analyst Company
- -
(2) no part of his or her compensation was, is or will be directly or indirectly related to
the specific recommendations or views expressed in this report.
BANGKOK SINGAPORE
RHB Securities (Thailand) PCL RHB Bank Berhad (Singapore branch)
10th Floor, Sathorn Square Office Tower 90 Cecil Street
98, North Sathorn Road, Silom #04-00 RHB Bank Building
Bangrak, Bangkok 10500 Singapore 069531
Thailand Fax: +65 6509 0470
Tel: +66 2088 9999
Fax :+66 2088 9799